维普中文期刊产品整合服务
19篇 您的检索式:作者名="Kramer GW"
    题名 作者 年代 出处 被引量
1Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage Ⅲ AN2 non-small cell lung cancer:a phase Ⅱ study of the European Organization for Research Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)显示文摘Van Zandwijk N Smit EF Kramer GW 2000J Clin Oncol2000,18,:1
2Randomized controlled trail of resection versus radiotherapy after induction chemotherapy in stage Ⅲ A-N2 non-small cell lung cancer 显示文摘van Meerbeek JP Kramer GW vart Schil PE 2007Natl Cancer Inst2007,99,:1
3Gemcitabine and cisplatin as induction regimen for patients with biopsy proven Stage Ⅲ A N2 non-small-cell lung cancer:a phase Ⅱ study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)显示文摘Van Zandwijk Smit EF Kramer GW 2000J Clin Oncol2000,18,:1
4Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage Ill A-N2 non-small- cell lung cancer显示文摘Van Meerbeeck J Kramer GW Van Schil PE 2007J Natl Cancer Inst2007,99,:1
5Dose downstaging in patients with IlIA-N2 non-small cell lung cancer (NSCLC)and a response to induction chemotherapy (ICT)influence outcome with surgery or radiotherapy:An exploratory analysis of EORTC 08941 显示文摘Van Meerbeeck JP Kramer GW Legrand C 2006J Clin Oncol2006,24,18:1
6Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer 显示文摘van-Meerbeeck JP Kramer GW Van-Schil PE 2007J Natl Cancer Inst2007,99,6:1
7Results of the Dutch National Study of the palliative effect of irradiation using two different treatment schemes for Non-small Cell Lung Cancer显示文摘Kramer GW Wanders SL Noordijk EM 2005J Clin Oncol2005,23,:1
8Gecitabine and cisplatin as induction regiment for patients with biopsy-proven stage ⅢaN2 non-small cell lung cancer: a phase Ⅱ study of the European Organization for Reseach and Treatment of Cancer lung cancer cooperative group (EORTC 08955)显示文摘 Smit EF Kramer GW 2000J Clin Oncol2000,18,:1
9Results of the Dutch National study of the palliative effects of irradiation using two different treatment schemes for non-small-cell lung cancer显示文摘Kramer GW Wanders SL Noordijk EM 0,,:1
10Randomized controlled trail of resection versus radiotherapy after induction chemotherapy in stage Ⅲ A-N2 non-small-cell lung cancer 显示文摘Van Meerbeeck JP Kramer GW van Schil PE 2007J Natl Cancer Inst2007,99,44:1
11Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage Ⅲ A N2 non-small cell lung cancer:a phase Ⅱ study of the Europan organization for research and treatment of cancer显示文摘Van Zandwijk N Smit EF Kramer GW 2000J Clin Oncol2000,18,14:1
12Randomized controlled trial of resection versus radiotherapy after induction chemo- therapy in stage II1A-N2 non-small-cell lung cancer显示文摘van Meerbeeek JP Kramer GW van Schil PE 2007J Natl Canc- er Inst2007,99,:1
13Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer显示文摘Kramer GW Wanders SL Noordijk EM 2005J Clin Oncol2005,23,13:1
14Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stageⅢ A-N2 nonesmall-cell lung cancer显示文摘van Meerbeeck JP Kramer GW Van Sehil PE 2007J Natl Cancer Inst2007,99,5:1
15Gemcitabine and cisplatin as induction regimen for patients with biopsyproven stage ⅢA N2 non-small-cell lung cancer:a phase Ⅱ study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)显示文摘Van Zandwijk N Smit EF Kramer GW 2000J Clin Oncol2000,18,14:1
16Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury显示文摘Kramer AS Harvey AFt Plant GW 2013Cell Transplant2013,22,:1
17Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage ⅢA-N2 Non-small Cell Lung Cancer显示文摘Van Meerbeeck J Kramer GW Van Schil PE 2007J Natl Cancer Inst2007,99,:1
18Dose downstaging in patients with ⅢA-N2 Non-small Cell Lung Cancer(NSCLC)and a response to induction chemotherapy(ICT)influence outcome with surgery or radiotherapy:An exploratory analysis of EORTC 08941显示文摘Van Meerbeeck JP Kramer GW Legrand C 2006J Clin Oncol2006,24,18:1
19Dose downstag- ing in paients With ⅢA-N2 Non-small Cell Lung Cancer (NSCLC) and a respanese to induction chemothrapy (ICT) influence outcome with surgery or radiotherapey: An exploratory analysis of EORTC 08941 显示文摘Van Meerbeek JP Kramer GW Legrand C 2006J Clin Oncol2006,24,18:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费